Apollo Hospitals Share Price Jumps 5% as Q1 Net Profit Rises 42%

Market Performance

Apollo Hospitals share price surged nearly 5% in early trade on Wednesday, August 13, 2025, after the company reported a strong financial performance for the quarter ended June 30, 2025.

At 9:20 a.m., the stock was trading at ₹7,591 on the NSE, up 4.9% from the previous close.

Main News

Apollo Hospitals Enterprise Ltd posted a 42% year-on-year jump in consolidated net profit to ₹433 crore in Q1 FY26.

The growth was fueled by robust performance across its Healthcare Services, Diagnostics, and Digital Health segments.

The company also launched new initiatives during the quarter, including Apollo Zen, an AI-driven preventive health program, and OraLife, aimed at early detection of oral cancer.

Additionally, Apollo outlined expansion plans to add over 4,300 beds in the next five years with an investment of ₹7,600 crore, including major projects in Bengaluru and Hyderabad.

Financial Performance – Q1 FY26

• Revenue: ₹5,842 crore (+15% YoY)
• EBITDA: ₹852 crore (+26% YoY)
• EBITDA Margins: Improved due to operational efficiencies
• Net Profit: ₹433 crore (+42% YoY)

Segment Highlights

Hospitals Segment

• Revenue up 11% YoY
• Inpatient volumes grew 3%
• Average Revenue Per Patient (ARPP) rose 11%
• Margins improved by 89 bps
• Occupancy rate stood at 65% (down 300 bps YoY)

HealthCo Segment

• Revenue up 19% YoY
• Margins improved by 41 bps
• Turned PAT positive

Company Details

Chairman Dr. Prathap C Reddy credited the company’s performance to Apollo’s integrated care model and sustained investments in digital platforms and infrastructure. He emphasized that the three growth engines—Healthcare Services, Retail Health & Diagnostics, and Digital & Pharma Distribution—are all contributing significantly to growth.

Summary

Apollo Hospitals share price gained sharply after the company posted strong Q1 FY26 results, with double-digit growth in revenue, EBITDA, and net profit. Apollo’s strategic expansions, tech-driven healthcare initiatives, and consistent performance across all business segments have strengthened its position as a leading player in India’s healthcare industry.